3/28
12:01 pm
ctlt
Softgel Capsules Market Size, Share & Trends Analysis Report 2023-2030, Featuring Fuji Capsule, Sirio Pharma, CAPTEK Softgel, Catalent, EuroCaps, Aenova, ProCaps Laboratories and Soft Gel Technologies [Yahoo! Finance]
Low
Report
Softgel Capsules Market Size, Share & Trends Analysis Report 2023-2030, Featuring Fuji Capsule, Sirio Pharma, CAPTEK Softgel, Catalent, EuroCaps, Aenova, ProCaps Laboratories and Soft Gel Technologies [Yahoo! Finance]
3/27
11:17 am
ctlt
Ozempic, Novo's $1,000 Diabetes Drug, Can Be Made for Less Than $5 a Month, Study Says [BNN Bloomberg (Canada)]
Low
Report
Ozempic, Novo's $1,000 Diabetes Drug, Can Be Made for Less Than $5 a Month, Study Says [BNN Bloomberg (Canada)]
3/26
02:31 am
ctlt
Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/25
11:57 am
ctlt
Clinical Trial Supply & Logistics Market Projected to Reach $41.04 billion by 2030 - Exclusive Report by 360iResearch [Yahoo! Finance]
Low
Report
Clinical Trial Supply & Logistics Market Projected to Reach $41.04 billion by 2030 - Exclusive Report by 360iResearch [Yahoo! Finance]
3/21
09:04 am
ctlt
Global Contract Development and Manufacturing Organization (CDMO) Analysis Report 2024: Market to Reach $256.9 Billion in 2029, Driven by Growing Biologics, Orphan Drugs, and Emerging Markets [Yahoo! Finance]
Low
Report
Global Contract Development and Manufacturing Organization (CDMO) Analysis Report 2024: Market to Reach $256.9 Billion in 2029, Driven by Growing Biologics, Orphan Drugs, and Emerging Markets [Yahoo! Finance]
3/18
02:13 am
ctlt
Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/13
12:13 pm
ctlt
$69.7 Billion Oral Solid Dosage Contract Manufacturing Market Assessment 2024-2034 Featuring Lonza Group, Catalent, Recipharm [Yahoo! Finance]
Low
Report
$69.7 Billion Oral Solid Dosage Contract Manufacturing Market Assessment 2024-2034 Featuring Lonza Group, Catalent, Recipharm [Yahoo! Finance]
3/13
11:24 am
ctlt
Global Oral Solid Dosage Contract Manufacturing Market 2024-2030: Regional Trends for Tablets, Capsules, Powders, and Granules [Yahoo! Finance]
Low
Report
Global Oral Solid Dosage Contract Manufacturing Market 2024-2030: Regional Trends for Tablets, Capsules, Powders, and Granules [Yahoo! Finance]
3/12
10:46 am
ctlt
Cellipont Bioservices Appoints Edwin Beale as Chief Commercial Officer [Yahoo! Finance]
Neutral
Report
Cellipont Bioservices Appoints Edwin Beale as Chief Commercial Officer [Yahoo! Finance]
3/11
08:22 pm
ctlt
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT
3/10
01:01 am
ctlt
Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/9
12:00 pm
ctlt
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT
3/9
09:05 am
ctlt
INVESTIGATION UPDATE: Halper Sadeh LLC Investigates CTLT, EVBG, FREE, KNTE
Low
Report
INVESTIGATION UPDATE: Halper Sadeh LLC Investigates CTLT, EVBG, FREE, KNTE
3/8
08:20 am
ctlt
Novo Nordisk hopes to launch experimental obesity drug this decade [Globe and Mail, The (Toronto, Canada)]
Low
Report
Novo Nordisk hopes to launch experimental obesity drug this decade [Globe and Mail, The (Toronto, Canada)]
3/8
07:19 am
ctlt
Novo Nordisk hopes to launch experimental obesity drug this decade [Reuters]
Low
Report
Novo Nordisk hopes to launch experimental obesity drug this decade [Reuters]
3/8
07:18 am
ctlt
Novo Nordisk hopes to launch experimental obesity drug this decade [Yahoo! Finance]
Low
Report
Novo Nordisk hopes to launch experimental obesity drug this decade [Yahoo! Finance]
3/7
04:55 pm
ctlt
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT
3/7
11:03 am
ctlt
Novo Nordisk will raise capex if Catalent deal is not completed, CFO says [Yahoo! Finance]
Low
Report
Novo Nordisk will raise capex if Catalent deal is not completed, CFO says [Yahoo! Finance]
3/7
08:08 am
ctlt
Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment [Yahoo! Finance]
Low
Report
Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment [Yahoo! Finance]
3/7
08:02 am
ctlt
Global Softgel Capsules Market Size is Estimated to Reach USD 14.86 billion by 2030, Growing at a CAGR of 7.81%: Straits Research [Yahoo! Finance]
Low
Report
Global Softgel Capsules Market Size is Estimated to Reach USD 14.86 billion by 2030, Growing at a CAGR of 7.81%: Straits Research [Yahoo! Finance]
3/7
08:00 am
ctlt
Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment
Low
Report
Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment
3/7
03:02 am
ctlt
Novo Nordisk to present early drug trial data, Wegovy supply update [Yahoo! Finance]
Low
Report
Novo Nordisk to present early drug trial data, Wegovy supply update [Yahoo! Finance]
3/5
02:05 pm
ctlt
Global Life Sciences BPO Markets, Trends, Opportunities, & Forecast, 2028F - Rising Cost Efficiency and Specialized Expertise Demand [Yahoo! Finance]
Low
Report
Global Life Sciences BPO Markets, Trends, Opportunities, & Forecast, 2028F - Rising Cost Efficiency and Specialized Expertise Demand [Yahoo! Finance]
3/5
01:07 am
ctlt
Eli Lilly races to boost capacity for rival to Novo Nordisk weight-loss drug [FT.com - Mergermarket]
Low
Report
Eli Lilly races to boost capacity for rival to Novo Nordisk weight-loss drug [FT.com - Mergermarket]
3/2
10:41 am
ctlt
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, KAMN, AVRO
Low
Report
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, KAMN, AVRO